THE CORRECTION OF MELATONIN-PRODUCING FUNCTION VIOLATIONS OF PINEAL GLAND IN ELDERLY PEOPLE WITH SUBSTITUTIVE DOSES OF MELATONIN AND EPIPHYSIS PEPTIDE DRUGS

Authors

  • Antoniuk-Shcheglova I. A. SI «D. Chebotaryov Institute of Gerontology of the NAMS of Ukraine», Kyiv

DOI:

https://doi.org/10.21856/j-PEP.2013.4.01

Keywords:

pineal gland, melatonin-producing function, peptide drugs, elderly people, correction

Abstract

The article presents data on the use of different doses of melatonin (0.5, 1.5, 3 mg) and peptide drugs for correcting violations of age-dependent melatonin-producing function of the pineal gland. It was found that to compensate of functional failure of pineal gland for elderly people enough to take melatonin at a dose 0.5 mg in the evening (the level of night excretion of 6-hydroxymelatoninsulfate (6-HMS) increased to the level in healthy young people). Using of melatonin in doses 3 mg and even 1.5 mg led to excessive increase in excretion of 6-HMS. After discontinuation of melatonin medication were not observed laboratory signs of decrease of the functional state of the pineal gland. In the older people peptide drugs of epiphysis (Epithalamin — a complex of peptides isolated from the gland, and Epithalon — synthetic tetrapeptide) was reduced nocturnal endogenous melatonin production, which was accompanied by normalization of the circadian rhythm of the hormone concentration in the blood plasma. In the older people Epithalamin and Epithalon had a modulating effect on the functional state of the pineal gland: nocturnal melatonin levels increased in people with functional deficiency of the gland. Epithalon in much lesser course dose (0.1 mg) resulted in the same effect as a larger dose of Epithalamin (50 mg).

References

Anisimov VN. Ros Fiziol Zhurn im IM Sechenova 1997; 83(8):1–13.

Reiter RJ, Tan DX, Mayo JC, et al. Free Radic Res 2002; 35(12): 1323-1329.

Goncharova ND, Havinson VH, Lapin BA. Pineal’naja zheleza vozrastnaja patologija (mehanizmy i korrekcija), Sankt-Peterburg, 2007: 168 p.

Korkushko OV, Havinson VH, Shatilo VB, et al. Uspehi Gerontologii 2004; 15:70-75.

Hendrick JC, Crasson M, Hagelstein MT, et al. Ann Endocrinol 2002; 63(1):3-7.

Magri F, Sarra S, Cinchetti W, et al. Pineal Res 2004; 36(4):256-261.

Korkushko OV, Shatylo VB, Antonjuk-Shheglova YA, Pysaruk AV Bukov med visn 2006; 10(4):80-86.

Girotti L, Lago M, Ianovsky O, et al. J Pineal Res 2000; 29(3):138–142.

Skene DJ, Swaab DF Exp Gerontol 2003; 38(1–2):199–206.

Cugini P, Touitou Y, Bogdan A, et al. Chronobiol Int 2001; 18(1):99–107.

Reiter RJ, Robinson J. Melatonin: Your body’s natural wonder drug, New York, 1995: 456 p.

Anisimov VN. Melatonin: rol’ v organizme, primenenie v klinike, Sankt-Peterburg, 2007: 40 p.

Carr DB. J Clin Endocrinol Metabol 1981; 53:224-225.

Bondarenko LA. Bjul Jeksperim Biologii i Mediciny 2004; 137(5):493-494.

Touitou Y. Exp Gerontol 2001; 36(7):1083–1100.

Anisimov VN, Bondarenko LA, Khavinson VKh. Ann NY Acad Sci 1992; 673:53-57.

Havinson VH, Anisimov VN. Peptidnye bioreguljatory i starenie, Sankt-Peterburg, 2003: 223 p.

Goncharova ND, Vengerin AA, Khavinson VK, Lapin BA. Exp Gerontol 2005; 40(1-2):51-57.

Butenko GM, Korkushko OV, Labunec IF, et al. Zhurn AMN Ukrainy 2002; 8(3):457-471.

Pawlikowski M, Kolomecka M, Wojtczak A, Karasek M. Neuroendocrinol Lett 2002; l:17-19.

Bellipanni G, Bianchi P, Pierpaoli W, et al. Exp Gerontol 2001; 36(2):297–310.

Goncharova ND, Vengerin AA, Shmalij AV, Havinson VH. Uspehi Gerontol 2003; 12:121–127.

Goncharova ND, Havinson VH, Lapin BA. Bjull Jeksperim Biol. Med. 2001; 131(4):466-468.

Downloads

Published

2013-12-20

How to Cite

Antoniuk-Shcheglova, I. A. (2013). THE CORRECTION OF MELATONIN-PRODUCING FUNCTION VIOLATIONS OF PINEAL GLAND IN ELDERLY PEOPLE WITH SUBSTITUTIVE DOSES OF MELATONIN AND EPIPHYSIS PEPTIDE DRUGS. Problems of Endocrine Pathology, 46(4), 7-17. https://doi.org/10.21856/j-PEP.2013.4.01

Issue

Section

CLINICAL ENDOCRINOLOGY